Browsing by Author Joly, Florence

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2007Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant miceGrau, Georges; Barbier, Mathieu; Benech, Philippe; Coltel, Nicolas; Delahaye, Nicolas; Iraqi, Fuad; Joly, Florence; Nguyen, Catherine; Puthier, Denis; Rihet, Pascal; School of Medical Sciences: PathologyGene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice, BMC Genomics, vol.8,(452),2007,pp 1-16
2014Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian CancerKing, Madeleine; Lee, Chee Khoon; Stockler, Martin; Arranz, José Angel; de Gregorio, Nikolaus; et al, Various; Friedlander, Michael; Hilpert, Felix; Joly, Florence; Mirza, Mansoor Raza; Wenzel, Lari; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePatient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer, Journal of Clinical Oncology, vol.32, 13, 2014,pp 1309-1319
2010Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late RelapseBrown, Christopher; Gebski, Val; Aavall-Lundqvist, Elisabeth; du Bois, Andreas; Ferrero, Annamaria; Heywood, Mark; Jackisch, Christian; Joly, Florence; Kristensen, Gunnar; Le Fur, Nathalie; Lortholary, Alain; Pignata, Sandro; Pujade-Lauraine, Eric; Sehouli, Jalid; Vasey, Paul A.; Vergote, Ignace; Volgger, Birgit; Wagner, Uwe; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse, Journal of Clinical Oncology, vol.28, 20,pp 3323-3329